Philips Healthcare CEO Departs With Unit’s Shift To More Streamlined Management
This article was originally published in The Gray Sheet
Executive Summary
CEO Deborah DiSanzo’s position has been eliminated as the Philip’s health care division responds to weak performance and implements a longer-term improvement initiative.
You may also be interested in...
Philips Emphasizes Services With New Division: Q&A With Jeroen Tas
Philips Healthcare announced the launch of its new Informatics Solutions and Services business last month. The division’s head, Jeroen Tas, spoke with “The Gray Sheet about the new effort.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.